Mobile Health to Promote Physical Activity Post Stroke

The proportion of participants screened who will be deemed eligible for the trial and the proportion of those consented who will be randomized to the trial.

Contrasting the demographic details of study sample with national data.

Number of participants who will not complete the trial.

Number of intervention sessions not completed and the reason for uncompleted sessions.

Performed exercise dose (i.e. number of sessions).

Performed exercise intensity assessed using the Borg Rating of Perceived Exertion Scale. The Borg Rating of Perceived Exertion Scale assess perceived exertion based on a 6 to 20 rating scale (higher score = higher perceived exertion).

Performance of individual physical activity counseling.

Provision of information on physical activity and health.

Establishment of individual physical activity goals.

Performance of structured follow-ups of goal fulfillment.

Adherence to treatment schedules.

Adherence to assessment schedules.

Adverse events may include falls, injuries, gastrointestinal issues requiring medical review or cardiac events. Trial therapists will record any adverse events that occur during telehealth sessions, and participants will answer a study specific questionnaire at the commencement of each exercise session, and at each assessment to self-report any adverse events that occur at other times during the study.

Systolic blood pressure measured with a portable blood pressure monitor (Omron M7 Intelli IT-AFIB), to be measured 3 times in the morning and afternoon for 7 days consecutively (minimum 3 days or 6 measures required to be used in the project evaluation).

Walking time (minutes) per day as measured by the ActivPal accelerometer to be worn continuously for 7 consecutive days (minimum of 3 days data required to be used in the evaluation)

Number of daily steps as measured by the ActivPal accelerometer to be worn continuously for 7 consecutive days (minimum of 3 days data required to be used in the evaluation)

Standing time (minutes) per day as measured by the ActivPal accelerometer to be worn continuously for 7 consecutive days (minimum of 3 days data required to be used in the evaluation)

Sitting time (minutes) per day as measured by the ActivPal accelerometer to be worn continuously for 7 consecutive days (minimum of 3 days data required to be used in the evaluation)

Generic Walk-12 Scale:

• 12 item scores summed to a total score with a possible range between 0 and 42 (higher score = more walking difficulties).

Activities-Specific Balance Confidence scale

• 16 item scores averaged to a mean score with a possible range between 0 to 100 (higher score = higher balance confidence).

Exercise Self-Efficacy Scale

• 9 item scores averaged to a mean score with a possible range between 0 to 100 (higher score = highly confident to exercise).

Fatigue Severity Scale

• 9 item scores summed to a total score with a possible range between 9 and 63 (higher score = greater fatigue severity).

Depression Anxiety Stress Scale (DASS-21)

• DASS-21 contains 21 questions divided in 3 subscales (depression, anxiety and stress) with 7 items on each scale. Each sub-scale is summed into a total score with a possible range between 0 and 24 (higher score = higher levels of symptoms related to depression/anxiety/stress).

EuroQuol-5 Dimensions (EQ5D)

EQ5D comprises:

• 5-items survey (mobility, self-care, usual activities, pain/discomfort and anxiety/depression), resulting in a 5-digit summary index which describes the patient's health state.
• Assessment of the person's self-rated health on a vertical visual analogue scale (VAS), where the endpoints are labelled 'The best health you can imagine' and 'The worst health you can imagine'. The VAS scale (ranging between 0 to 100, higher value = better self-rated health).